Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · IEX Real-Time Price · USD

22.52

-0.15 (-0.66%)

At close: Apr 25, 2024, 4:00 PM

22.02

-0.50 (-2.22%)

After-hours: Apr 25, 2024, 7:05 PM EDT

Bicycle Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	956	767	879	1,790	382	169
Market Cap Growth	-	-12.72%	-50.89%	367.96%	126.52%	-
Enterprise Value	469	281	581	1,393	261	78
PE Ratio	-4.24	-4.24	-7.80	-26.78	-7.50	-5.52
PS Ratio	35.42	28.43	60.76	152.99	36.81	12.23
PB Ratio	2.58	2.07	3.25	5.17	4.01	1.81
P/FCF Ratio	-12.07	-12.07	-8.36	-106.37	-20.14	-5.60
P/OCF Ratio	-12.65	-12.65	-10.21	-120.97	-21.50	-5.90
EV/Sales Ratio	17.39	10.40	40.16	119.08	25.16	5.65
EV/EBITDA Ratio	-1.66	-1.66	-5.42	-21.73	-5.23	-2.61
EV/EBIT Ratio	-1.60	-1.60	-5.24	-21.27	-5.10	-2.53
EV/FCF Ratio	-4.42	-4.42	-5.53	-82.79	-13.76	-2.58
Debt / Equity Ratio	0.11	0.11	0.15	0.12	0.16	0.01
Debt / EBITDA Ratio	-0.24	-0.24	-0.38	-0.65	-0.30	-0.04
Debt / FCF Ratio	-0.63	-0.63	-0.39	-2.49	-0.79	-0.04
Quick Ratio	7.92	7.92	6.76	12.43	6.51	11.25
Current Ratio	8.08	8.08	6.93	12.65	6.73	11.81
Asset Turnover	0.05	0.05	0.03	0.04	0.07	0.14
Interest Coverage	-53.92	-53.92	-33.16	-21.95	-112.20	-
Return on Equity (ROE)	-57.80%	-57.80%	-37.50%	-33.40%	-57.00%	-261.90%
Return on Assets (ROA)	-34.10%	-34.10%	-26.00%	-22.10%	-35.20%	-31.90%
Return on Capital (ROIC)	-46.21%	-46.21%	-37.39%	-16.90%	-47.07%	-27.84%
Earnings Yield	-18.91%	-23.56%	-12.83%	-3.73%	-13.34%	-18.13%
FCF Yield	-6.65%	-8.29%	-11.96%	-0.94%	-4.97%	-17.87%
Buyback Yield / Dilution	-20.00%	-20.00%	-18.35%	-30.90%	-73.34%	-2416.82%
Total Shareholder Return	-20.00%	-20.00%	-18.35%	-30.90%	-73.34%	-2416.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).